Epstein-Peterson ZD, Drill E, Aypar U, Batlevi CL, et al. Erratum to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation. Haematologica 2024;109:2749-2752.
PMID: 39087412